Daratumumab 100mg/5ml solution for infusion vials

SNOMED code
32887211000001109
Active compound
Daratumumab
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
5 ml, vial
Ingredients
Daratumumab — 20 mg / 1 ml based on ingredient substance
Form & Route
solutioninfusion.intravenous
Solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Darzalex 100mg/5ml concentrate for solution for infusion vials (Janssen-Cilag Ltd)

in short Darzalex 100mg/5ml concentrate for inf vials

Darzalex 100mg/5ml concentrate for solution for infusion vials

SNOMED code
32887311000001101
Supplier
Janssen-Cilag Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Darzalex 100mg/5ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) 1 vial
32887511000001107   ref. pack
💯 Available

Legal category: POM
5012674902899
05012674902899
05012674903889
NHS Indicative Price
£360
• Hospital
  • • Prescription Charges

Reference packs

Daratumumab 100mg/5ml solution for infusion vials 1 vial
SNOMED code
32887411000001108
Quantity and unit
1 vial
Packs